Can six weeks of leg presses recharge aging muscles?

NCT ID NCT07828847

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers are investigating how mitochondria, the energy-producing structures inside muscle cells, relate to frailty in older adults. The study includes about 120 people: older adults with type 2 diabetes, healthy older adults, and healthy young adults. Everyone does a six-week supervised resistance training program with leg press and quadriceps exercises. Before and after training, researchers measure muscle strength, physical function, body composition, blood markers, gut bacteria, and in some participants, muscle tissue samples to assess mitochondrial activity and gene expression.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a six-week supervised resistance training program using leg press and quadriceps extension exercises
What this could lead to
If resistance training changes muscle mitochondria in measurable ways, it could help explain why exercise protects older adults from frailty and guide exercise programs for people with type 2 diabetes.
What could go wrong
This is a small, short study that measures biological markers rather than long-term health outcomes. Six weeks of training may not be enough to change frailty or mitochondrial function in a way that matters, and results in this group may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 83 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion criteria for young controls * Healthy young adults (18-35 years old) * Without any pathology or treatment * Inclusion criteria for older controls * Healthy older adults (65 years or older) * Not currently enrolled in a resistance training program * Inclusion criteria for cases * Age over 65 years * Diagnosis of frailty or robustness * Diagnosis of type 2 diabetes mellitus * Glycosylated hemoglobin (HbA1c) less than 9% * Treatment with metformin * Not currently enrolled in a resistance training program Exclusion Criteria: * Exclusion criteria for young controls * Pregnancy or suspected pregnancy * Body mass index greater than 35 kg/m2 * Treatment within the last 30 days with oral corticosteroids * Edema or severe fluid regulation disorders that could alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Prostheses, metal implants, or surgical staples lodinated or barium contrast for other imaging tests within the last 7 days * Exclusion criteria for older controls * Decompensated and uncontrolled chronic diagnoses * Body mass index greater than 35 kg/m2 * Treatment within the last 30 days with oral corticosteroids * Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease (COPD). * Severe edema or fluid regulation disorders that could alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Prostheses, metal implants, or surgical staples Iodinated or barium contrast for other imaging tests in the last 7 days * Exclusion criteria for cases * Diagnosis of pre-frailty * Age over 80 years * Body mass index greater than 35 kg/m2 * Time since onset of diabetes mellitus type 2 less than 10 years * Treatment with insulin * Treatment with allopurinol * Treatment with anticoagulant or antiplatelet drugs * Treatment within the last 30 days with oral corticosteroids * Advanced chronic complications of diabetes mellitus type 2 : Renal failure (clearance \<30 ml/min/m2) Macroalbuminuria greater than 200 mg/g Ischemic vascular diseases (acute myocardial infarction) Myocardial infarction, angina, stroke) Proliferative retinopathy or laser therapy Ulcerated diabetic foot or lower limb amputations, except for digital amputations * Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease * Physical limitations in the lower limbs (acute or acute-on-chronic inflammatory processes, limited joint range of motion, chronic pain (visual analogue scale for pain \> or = 4, etc.) * Senile dementia * Edema or severe fluid regulation disorders that may alter bioimpedance results * Allergy to the local anesthetic mepivacaine * Pacemaker, metallic prostheses or implants, surgical staples, and radiopaque tubes or catheters Iodinated or barium contrast for other imaging tests within the last 7 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Valencia/Hospital Clínico Universitario de València,

    RECRUITING

    Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.